TipRanks
Johnson & Johnson (DE:JNJ)
XETRA:JNJ
Germany Market
JNJ
Johnson & Johnson
RESEARCH TOOLSreports

Johnson & Johnson (JNJ) Stock Forecast & Price Target

152 Followers
See the Price Targets and Ratings of:

JNJ Analyst Ratings

Strong Buy
18Ratings
Strong Buy
14 Buy
4 Hold
0 Sell
Based on 18 analysts giving stock ratings to
Johnson
& Johnson
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

JNJ Stock 12 Month Forecast

Average Price Target

€257.69
▲(12.38% Upside)
Based on 18 Wall Street analysts offering 12 month price targets for Johnson & Johnson in the last 3 months. The average price target is €257.69 with a high forecast of €285.39 and a low forecast of €231.88. The average price target represents a 12.38% change from the last price of €229.30.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"152":"€152","219":"€219","286":"€286","185.5":"€185.5","252.5":"€252.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":285.385584,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€285.39</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":257.68930944166664,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€257.69</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":231.875787,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€231.88</span>\n  </div></div>","useHTML":true}}],"tickPositions":[152,185.5,219,252.5,286],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,233.05,237.07581415384615,241.10162830769232,245.12744246153846,249.15325661538463,253.17907076923078,257.2048849230769,261.2306990769231,265.2565132307692,269.28232738461537,273.30814153846154,277.33395569230765,281.3597698461538,{"y":285.385584,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,233.05,234.94533149551282,236.84066299102565,238.73599448653846,240.6313259820513,242.5266574775641,244.4219889730769,246.31732046858974,248.21265196410255,250.10798345961535,252.0033149551282,253.898646450641,255.79397794615383,{"y":257.68930944166664,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,233.05,232.95967592307693,232.86935184615385,232.77902776923077,232.6887036923077,232.59837961538463,232.50805553846155,232.41773146153847,232.32740738461538,232.2370833076923,232.14675923076925,232.05643515384617,231.96611107692308,{"y":231.875787,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":153.744,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":159.709,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":174.816,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":173.891,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":190.936,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":210.333,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":208.948,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":193.692,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":189.356,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":220.601,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":222.989,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":231.15,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 44,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":233.05,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€285.39Average Price Target€257.69Lowest Price Target€231.88
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners Analyst forecast on DE:JNJ
David Risinger
Leerink Partners
Leerink Partners
€246.15
Buy
7.35%
Upside
Reiterated
10/12/26
Johnson & Johnson (JNJ) Receives a Rating Update from a Top Analyst
Stifel Nicolaus Analyst forecast on DE:JNJ
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
€231.88
Hold
1.12%
Upside
Reiterated
10/12/26
Stifel Nicolaus Reaffirms Their Hold Rating on Johnson & Johnson (JNJ)
Bank of America Securities Analyst forecast on DE:JNJ
Jason Gerberry
Bank of America Securities
Bank of America Securities
€247.93→€251.5
Hold
9.68%
Upside
Reiterated
10/09/26
Johnson & Johnson price target raised to $282 from $278 at BofAJohnson & Johnson price target raised to $282 from $278 at BofA
UBS Analyst forecast on DE:JNJ
Michael Yee
UBS
UBS
€285.39
Buy
24.46%
Upside
Reiterated
10/09/26
Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (NYSE: JNJ), United Therapeutics (NASDAQ: UTHR) and Ionis Pharmaceuticals (NASDAQ: IONS)
Morgan Stanley Analyst forecast on DE:JNJ
Terence Flynn
Morgan Stanley
Morgan Stanley
€262.2
Buy
14.35%
Upside
Assigned
10/07/26
Morgan Stanley Releases a Buy Rating on Johnson & Johnson (JNJ)
RBC Capital Analyst forecast on DE:JNJ
Trung Huynh
RBC Capital
RBC Capital
€255.96→€258.63
Buy
12.79%
Upside
Reiterated
10/06/26
RBC Capital Keeps Their Buy Rating on Johnson & Johnson (JNJ)
Guggenheim Analyst forecast on DE:JNJ
Vamil Divan
Guggenheim
Guggenheim
€255.96
Buy
11.62%
Upside
Reiterated
10/06/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Aclaris Therapeutics (NASDAQ: ACRS), Globus Medical (NYSE: GMED) and Johnson & Johnson (NYSE: JNJ)
Citi Analyst forecast on DE:JNJ
Joanne Wuensch
Citi
Citi
€265.77→€270.22
Buy
17.85%
Upside
Reiterated
10/05/26
Johnson & Johnson price target raised to $303 from $298 at CitiJohnson & Johnson price target raised to $303 from $298 at Citi
Wells Fargo Analyst forecast on DE:JNJ
Larry Biegelsen
Wells Fargo
Wells Fargo
€251.5
Buy
9.68%
Upside
Assigned
10/02/26
Analysts Are Bullish on Top Healthcare Stocks: Johnson & Johnson (JNJ), Wave Life Sciences (WVE)
J.P. Morgan Analyst forecast on DE:JNJ
Chris Schott
J.P. Morgan
J.P. Morgan
€240.79→€254.17
Hold
10.85%
Upside
Reiterated
09/29/26
Johnson & Johnson price target raised to $285 from $270 at JPMorganJohnson & Johnson price target raised to $285 from $270 at JPMorgan
Scotiabank Analyst forecast on DE:JNJ
Louise Chen
Scotiabank
Scotiabank
€272.01
Buy
18.63%
Upside
Reiterated
09/28/26
Johnson & Johnson (JNJ) Gets a Buy from Scotiabank
TD Cowen Analyst forecast on DE:JNJ
Michael Nedelcovych
TD Cowen
TD Cowen
€267.55
Buy
16.68%
Upside
Reiterated
09/14/26
J&J: Oncology Momentum and Potential $20B DePuy Synthes Divestiture Support Nedelcovych Buy Rating
DBS Analyst forecast on DE:JNJ
Nico Chen
DBS
DBS
€240.79
Hold
5.01%
Upside
Reiterated
09/11/26
DBS Sticks to Their Hold Rating for Johnson & Johnson (JNJ)
HSBC Analyst forecast on DE:JNJ
Morten Herholdt
HSBC
HSBC
€258.63→€285.39
Buy
24.46%
Upside
Reiterated
09/10/26
Johnson & Johnson price target raised to $320 from $290 at HSBCJohnson & Johnson price target raised to $320 from $290 at HSBC
Goldman Sachs Analyst forecast on DE:JNJ
Asad Haider
Goldman Sachs
Goldman Sachs
€251.5
Buy
9.68%
Upside
Reiterated
08/25/26
Analysts Are Bullish on These Healthcare Stocks: Zymeworks (ZYME), Johnson & Johnson (JNJ)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners Analyst forecast on DE:JNJ
David Risinger
Leerink Partners
Leerink Partners
€246.15
Buy
7.35%
Upside
Reiterated
10/12/26
Johnson & Johnson (JNJ) Receives a Rating Update from a Top Analyst
Stifel Nicolaus Analyst forecast on DE:JNJ
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
€231.88
Hold
1.12%
Upside
Reiterated
10/12/26
Stifel Nicolaus Reaffirms Their Hold Rating on Johnson & Johnson (JNJ)
Bank of America Securities Analyst forecast on DE:JNJ
Jason Gerberry
Bank of America Securities
Bank of America Securities
€247.93→€251.5
Hold
9.68%
Upside
Reiterated
10/09/26
Johnson & Johnson price target raised to $282 from $278 at BofAJohnson & Johnson price target raised to $282 from $278 at BofA
UBS Analyst forecast on DE:JNJ
Michael Yee
UBS
UBS
€285.39
Buy
24.46%
Upside
Reiterated
10/09/26
Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (NYSE: JNJ), United Therapeutics (NASDAQ: UTHR) and Ionis Pharmaceuticals (NASDAQ: IONS)
Morgan Stanley Analyst forecast on DE:JNJ
Terence Flynn
Morgan Stanley
Morgan Stanley
€262.2
Buy
14.35%
Upside
Assigned
10/07/26
Morgan Stanley Releases a Buy Rating on Johnson & Johnson (JNJ)
RBC Capital Analyst forecast on DE:JNJ
Trung Huynh
RBC Capital
RBC Capital
€255.96→€258.63
Buy
12.79%
Upside
Reiterated
10/06/26
RBC Capital Keeps Their Buy Rating on Johnson & Johnson (JNJ)
Guggenheim Analyst forecast on DE:JNJ
Vamil Divan
Guggenheim
Guggenheim
€255.96
Buy
11.62%
Upside
Reiterated
10/06/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Aclaris Therapeutics (NASDAQ: ACRS), Globus Medical (NYSE: GMED) and Johnson & Johnson (NYSE: JNJ)
Citi Analyst forecast on DE:JNJ
Joanne Wuensch
Citi
Citi
€265.77→€270.22
Buy
17.85%
Upside
Reiterated
10/05/26
Johnson & Johnson price target raised to $303 from $298 at CitiJohnson & Johnson price target raised to $303 from $298 at Citi
Wells Fargo Analyst forecast on DE:JNJ
Larry Biegelsen
Wells Fargo
Wells Fargo
€251.5
Buy
9.68%
Upside
Assigned
10/02/26
Analysts Are Bullish on Top Healthcare Stocks: Johnson & Johnson (JNJ), Wave Life Sciences (WVE)
J.P. Morgan Analyst forecast on DE:JNJ
Chris Schott
J.P. Morgan
J.P. Morgan
€240.79→€254.17
Hold
10.85%
Upside
Reiterated
09/29/26
Johnson & Johnson price target raised to $285 from $270 at JPMorganJohnson & Johnson price target raised to $285 from $270 at JPMorgan
Scotiabank Analyst forecast on DE:JNJ
Louise Chen
Scotiabank
Scotiabank
€272.01
Buy
18.63%
Upside
Reiterated
09/28/26
Johnson & Johnson (JNJ) Gets a Buy from Scotiabank
TD Cowen Analyst forecast on DE:JNJ
Michael Nedelcovych
TD Cowen
TD Cowen
€267.55
Buy
16.68%
Upside
Reiterated
09/14/26
J&J: Oncology Momentum and Potential $20B DePuy Synthes Divestiture Support Nedelcovych Buy Rating
DBS Analyst forecast on DE:JNJ
Nico Chen
DBS
DBS
€240.79
Hold
5.01%
Upside
Reiterated
09/11/26
DBS Sticks to Their Hold Rating for Johnson & Johnson (JNJ)
HSBC Analyst forecast on DE:JNJ
Morten Herholdt
HSBC
HSBC
€258.63→€285.39
Buy
24.46%
Upside
Reiterated
09/10/26
Johnson & Johnson price target raised to $320 from $290 at HSBCJohnson & Johnson price target raised to $320 from $290 at HSBC
Goldman Sachs Analyst forecast on DE:JNJ
Asad Haider
Goldman Sachs
Goldman Sachs
€251.5
Buy
9.68%
Upside
Reiterated
08/25/26
Analysts Are Bullish on These Healthcare Stocks: Zymeworks (ZYME), Johnson & Johnson (JNJ)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ONCBeOne Medicines
OVIDOvid Therapeutics
ASNDAscendis Pharma
QNCXQuince Therapeutics
EHCEncompass Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Johnson & Johnson

3 Months
Asad HaiderGoldman Sachs
Success Rate
12/15 ratings generated profit
80%
Average Return
+9.33%
Copying Asad Haider's trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +9.33% per trade.
1 Year
Vamil DivanGuggenheim
Success Rate
20/21 ratings generated profit
95%
Average Return
+14.03%
Copying Vamil Divan's trades and holding each position for 1 Year would result in 95.24% of your transactions generating a profit, with an average return of +14.03% per trade.
2 Years
Vamil DivanGuggenheim
Success Rate
20/21 ratings generated profit
95%
Average Return
+20.23%
Copying Vamil Divan's trades and holding each position for 2 Years would result in 95.24% of your transactions generating a profit, with an average return of +20.23% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

JNJ Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
26
37
41
44
27
Hold
9
8
7
10
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
35
45
48
54
33
In the current month, JNJ has received 27 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. JNJ average Analyst price target in the past 3 months is 257.69.
Each month's total comprises the sum of three months' worth of ratings.

JNJ Financial Forecast

JNJ Earnings Forecast

Next quarter’s earnings estimate for JNJ is €2.25 with a range of €2.06 to €2.51. The previous quarter’s EPS was €2.59. JNJ beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year JNJ has Performed in-line its overall industry.
Next quarter’s earnings estimate for JNJ is €2.25 with a range of €2.06 to €2.51. The previous quarter’s EPS was €2.59. JNJ beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year JNJ has Performed in-line its overall industry.

JNJ Sales Forecast

Next quarter’s sales forecast for JNJ is €22.64B with a range of €22.37B to €22.92B. The previous quarter’s sales results were €22.58B. JNJ beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year JNJ has Performed in-line its overall industry.
Next quarter’s sales forecast for JNJ is €22.64B with a range of €22.37B to €22.92B. The previous quarter’s sales results were €22.58B. JNJ beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year JNJ has Performed in-line its overall industry.

JNJ Stock Forecast FAQ

What is DE:JNJ’s average 12-month price target, according to analysts?
Based on analyst ratings, Johnson & Johnson’s 12-month average price target is 257.69.
    What is DE:JNJ’s upside potential, based on the analysts’ average price target?
    Johnson & Johnson has 12.38% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Johnson & Johnson a Buy, Sell or Hold?
          Johnson & Johnson has a consensus rating of Strong Buy, which is based on 14 buy ratings, 4 hold ratings and 0 sell ratings.
            What is Johnson & Johnson’s share price target?
            The average share price target for Johnson & Johnson is 257.69. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €285.39 ,and the lowest forecast is €231.88. The average share price target represents 12.38% Increase from the current price of €229.3.
              What do analysts say about Johnson & Johnson?
              Johnson & Johnson’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Streets Analysts.
                How can I buy shares of Johnson & Johnson?
                To buy shares of DE:JNJ, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.